Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG, MAT

Information Update - Unauthorized workout and sexual enhancement supplements seized from "Atomik Nutrition" in Boucherville, QC, may pose serious health risks


OTTAWA, Aug. 9, 2018 /CNW/ - Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert. 

 

Unauthorized health products

Product &
Promoted Use

Hazard Identified

Company

Action Taken

51 50
Workout supplement

Labelled to contain rauvolfia

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

Insane Labz Psychotic
Workout supplement

Labelled to contain rauwolfia

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

NutraKey Yohimbine
Sexual enhancement

Labelled to contain yohimbine

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

Manson
Workout supplement

Labelled to contain rauwolfia

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

Psychotic Gold
Workout Supplement

Labelled to contain rauwolfia

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

Sidewalk Kraka

Workout supplement

Labelled to contain rauwolfia

Atomik Nutrition
450 boul. de Mortagne, Boucherville, QC

Seized from the retail location

 

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may have purchased and take appropriate action. Canadians are encouraged to check back regularly for updates.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 12:20
Global Regenerative Medicine Partnering Deals Analysis Report and Directory 2016-2024: 1771 Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
Diagnostic Imaging Partnering Analysis Report and Directory 2016-2024: 628 Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
Global Infectious Vaccine Partnering Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
Global Musculoskeletal Partnering Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
Pharmaceuticals and Biotechnology Option and Evaluation Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research & Licensing Deals by Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....

More news about Health...


News published on and distributed by: